These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6640533)

  • 1. Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5815-20. PubMed ID: 6640533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity.
    Sladek NE; Smith PC; Bratt PM; Low JE; Powers JF; Borch RF; Coveney JR
    Cancer Treat Rep; 1982 Nov; 66(11):1889-1900. PubMed ID: 7139634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
    Kwon CH; Maddison K; LoCastro L; Borch RF
    Cancer Res; 1987 Mar; 47(6):1505-8. PubMed ID: 3815352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Half-life of oxazaphosphorines in biological fluids.
    Sladek NE; Powers JF; Grage GM
    Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
    Sladek NE; Doeden D; Powers JF; Krivit W
    Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct detection of the intracellular formation of carboxyphosphamides using nuclear magnetic resonance spectroscopy.
    Boal JH; Ludeman SM; Ho CK; Engel J; Niemeyer U
    Arzneimittelforschung; 1994 Jan; 44(1):84-93. PubMed ID: 8135883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF
    Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract]   [Full Text] [Related]  

  • 11. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
    Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of degradation of cefazolin and cephalexin in aqueous solution.
    Rattie ES; Guttman DE; Ravin LJ
    Arzneimittelforschung; 1978; 28(6):944-8. PubMed ID: 35181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
    Kawabata TT; White KL
    Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
    Brock N
    Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of acrolein in 4-hydroperoxycyclophosphamide-induced cell damage in vitro.
    Blomgren H; Hallström M
    Methods Find Exp Clin Pharmacol; 1991; 13(1):11-4. PubMed ID: 1908032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines.
    Kohn FR; Sladek NE
    Biochem Pharmacol; 1985 Oct; 34(19):3465-71. PubMed ID: 2996550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of a votile factor from solutions of oxazaphosphorines which damage normal and malignant cells.
    Blomgren H; Hallström M
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):391-7. PubMed ID: 2747340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and aqueous chemistry of alpha-acetoxy-N-nitrosomorpholine: reactive intermediates and products.
    Zink CN; Kim HJ; Fishbein JC
    J Org Chem; 2006 Jan; 71(1):202-9. PubMed ID: 16388636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.